This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

The Treatment of Postpartum Depression: Minimizing Infant Exposures

D. Jeffrey Newport, MD; Amy Hostetter, BA; Angela Arnold, MD; and Zachary N. Stowe, MD

Published: July 1, 2002

Article Abstract

The first 3 postpartum months represent a high-risk period for psychiatric illnesses. This articlereviews the prevalence and diagnostic criteria for postpartum illnesses, including the “maternalblues,” postpartum depression, and postpartum psychosis. Pharmacologic treatment of these disordersis often complicated by a patient’s desire to breast-feed, yet there are no controlled trials of antidepressanttreatment during lactation. Infant exposure and limitations to monitoring infant sera arereviewed. Lastly, a model and guide for reducing fetal and infant exposures is presented.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Populations , Women

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...